InfuSystem Holdings (INFU) Gross Margin (2010 - 2026)
InfuSystem Holdings (INFU) reported Gross Margin of 58.43% for Q1 2026, up 322.0% on a YoY basis from 13.85% in Q1 2025, and up 3.6% quarter-over-quarter from 56.4% in Q4 2025.
InfuSystem Holdings (INFU) Gross Margin (2010 - 2026) Analysis & Trends
InfuSystem Holdings has reported Gross Margin for 17 years, with the latest figure at 58.43% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 322.0% year-over-year to 58.43%; the trailing twelve-month figure through Mar 2026 stood at 56.75% (up 362.0% YoY), and the FY2025 full-year result was 55.98%, up 378.0% from the prior year.
- Gross Margin for Q1 2026 stood at 58.43%, up from 56.4% in the prior quarter.
- The five-year high for Gross Margin was 59.46% in Q3 2022, with the low at 48.81% in Q4 2022.
- Historically, Gross Margin has averaged 53.67% across 5 years, with a median of 53.92% in 2024.
- Annual changes were most pronounced in 2023 — Gross Margin sank 1052 bps — and 2025, when it soared 574 bps.
- InfuSystem Holdings' Gross Margin stood at 48.81% in 2022, then climbed by 8 bps to 52.6% in 2023, then gained by 2 bps to 53.82% in 2024, then grew by 5 bps to 56.4% in 2025, then climbed by 4 bps to 58.43% in 2026.
- The last three Gross Margin figures came in at 58.43% (Q1 2026), 56.4% (Q4 2025), and 57.06% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 43.89% |
| 10 | InfuSystem Holdings | 189.78 Mn | 187.68 Mn | 19.68 Mn | 58.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.43% |
| Dec 31, 2025 | 56.40% |
| Sep 30, 2025 | 57.06% |
| Jun 30, 2025 | 55.20% |
| Mar 31, 2025 | 55.21% |
| Dec 31, 2024 | 53.82% |
| Sep 30, 2024 | 53.92% |
| Jun 30, 2024 | 49.46% |
| Mar 31, 2024 | 51.49% |
| Dec 31, 2023 | 52.60% |
| Sep 30, 2023 | 48.94% |
| Jun 30, 2023 | 49.89% |
| Mar 31, 2023 | 49.23% |
| Dec 31, 2022 | 48.81% |
| Sep 30, 2022 | 59.46% |
| Jun 30, 2022 | 55.10% |
| Mar 31, 2022 | 57.42% |
| Dec 31, 2021 | 51.45% |
| Sep 30, 2021 | 57.43% |
| Jun 30, 2021 | 60.60% |